1. Stephenson MD, Awartani KA, Robinson WP. Cytogenetic analysis of miscarriages from couples with recurrent miscarriage: a case-control study. Hum Reprod 2002; 17: 446-451. [
DOI:10.1093/humrep/17.2.446]
2. Sierra S, Stephenson M. Genetics of recurrent pregnancy loss. Semin Reprod Med 2006; 24: 17-24. [
DOI:10.1055/s-2006-931797]
3. Mei S, Tan J, Chen H, Chen Y, Zhang J. Changes of CD4+CD25+ high regulatory T cells and FOXP3 expression in unexplained recurrent spontaneous abortion patients. Fertil Steril 2010; 94: 2244-2247. [
DOI:10.1016/j.fertnstert.2009.11.020]
4. Hadinedoushan H, Mirahmadian M, Aflatounian A. Increased natural killer cell cytotoxicity and IL-2 production in recurrent spontaneous abortion. Am J Reprod Immunol 2007: 58: 409-414. [
DOI:10.1111/j.1600-0897.2007.00524.x]
5. Renaud SJ, Cotechini T, Quirt JS, Macdonald-Goodfellow SK, Othman M, Graham CH. Spontaneous pregnancy loss mediated by abnormal maternal inflammation in rats is linked to deficient uteroplacental perfusion. J Immunol 2011; 186: 1799-1808. [
DOI:10.4049/jimmunol.1002679]
6. Calleja-Agius J, Jauniaux E, Pizzey AR, Muttukrishna S. Investigation of systemic inflammatory response in first trimester pregnancy failure. Hum Reprod 2012; 27: 349-357. [
DOI:10.1093/humrep/der402]
7. Bao SH, Wang XP, De Lin Q, Wang WJ, Yin GJ, Qiu LH. Decidual CD4+ CD25+ CD127dim/ regulatory T cells in patients with unexplained recurrent spontaneous miscarriage. Eur J Obstet Gynecol Reprod Biol 2011; 155: 94-98. [
DOI:10.1016/j.ejogrb.2010.11.007]
8. Wang WJ, Hao CF, Yi L, Yin GJ, Bao SH, Qiu LH, et al.. Increased prevalence of T helper 17 (Th17) cells in peripheral blood and decidua in unexplained recurrent spontaneous abortion patients. J Reprod Immunol 2010; 84: 164-170. [
DOI:10.1016/j.jri.2009.12.003]
9. Hadinedoushan H, Najafi S, Eslami G, Aflatoonian A. Association of IL-17A and IL-17F gene polymorphisms with recurrent pregnancy loss in Iranian women. J Assist Reprod Gene 2014; 31: 1491-1496. [
DOI:10.1007/s10815-014-0294-0]
10. Stumhofer JS, Hunter CA. Advances in understanding the anti-inflammatory properties of IL-27. Immunol lett 2008; 117: 123-130. [
DOI:10.1016/j.imlet.2008.01.011]
11. Carl JW, Bai XF. IL27: its roles in the induction and inhibition of inflammation. Int J Clin Exp Pathol 2008; 1: 117-123
12. Yoshimura T, Takeda A, Hamano S, Miyazaki Y, Kinjyo I, Ishibashi T, et al. Two-sided roles of IL-27: induction of Th1 differentiation on naive CD4+ T cells versus suppression of proinflammatory cytokine production including IL-23-induced IL-17 on activated CD4+ T cells partially through STAT3-dependent mechanism. J Immunol 2006; 177: 5377-5385. [
DOI:10.4049/jimmunol.177.8.5377]
13. Sasaoka T, Ito M, Yamashita J, Nakajima K, Tanaka I, Narita M, et al. Treatment with IL-27 attenuates experimental colitis through the suppression of the development of IL-17- producing T helper cells. Am J Physiol Gastrointest Liver Physiol 2011; 300: G568-G576. [
DOI:10.1152/ajpgi.00329.2010]
14. Mao H, Gao W, Ma C, Sun J, Liu J, Shao Q, et al. Human placental trophoblasts express the immunosuppressive cytokine IL-35. Hum immunol 2013; 74: 872-877. [
DOI:10.1016/j.humimm.2013.04.010]
15. Pflanz S, Timans JC, Cheung J, Rosales R, Kanzler H, Gilbert J, et al. IL-27, a heterodimeric cytokine composed of EBI3 and p28 protein, induces proliferation of naive CD4+ T cells. Immunity 2002; 16: 779-790. [
DOI:10.1016/S1074-7613(02)00324-2]
16. Chae SC, Li CS, Kim KM, Yang JY, Zhang Q, Lee YC, et al. Identification of polymorphisms in human interleukin-27 and their association with asthma in a Korean population. J Hum Genet 2007; 52: 355-361. [
DOI:10.1007/s10038-007-0123-8]
17. Li CS, Zhang Q, Lee KJ, Cho SW, Lee KM, Hahm KB, et al. Interleukin‐27 polymorphisms are associated with inflammatory bowel diseases in a Korean population. J Gastroenterol Hepatol 2009; 24: 1692-1696. [
DOI:10.1111/j.1440-1746.2009.05901.x]
18. Zhang Z, Zhou B, Wu Y, Gao Q, Zhang K, Song Y, et al. Prognostic value of IL-27 polymorphisms and the susceptibility to epithelial ovarian cancer in a Chinese population. Immunogenetics 2014; 66: 85-92. [
DOI:10.1007/s00251-013-0753-2]
19. Batten M, Ghilardi N. The biology and therapeutic potential of interleukin 27. J Mol Med 2007; 85: 661-672. [
DOI:10.1007/s00109-007-0164-7]
20. Stumhofer JS, Silver JS, Laurence A, Porrett PM, Harris TH, Turka LA, et al. Interleukins 27 and 6 induce STAT3-mediated T cell production of interleukin 10. Nat Immunol 2007; 8: 1363-1371. [
DOI:10.1038/ni1537]
21. Hadinedoushan H, Mirahmadian M, Aflatounian A, Akbari F, Hatmi N. Cytokine production by peripheral blood mononuclear cells in recurrent miscarriage. Cytokine 2004; 28: 83-86. [
DOI:10.1016/j.cyto.2004.07.002]
22. Lee SK, Kim JY, Lee M, Gilman-Sachs A, Kwak-Kim J. Th17 and regulatory T cells in women with recurrent pregnancy loss. Am J Reprod Immunol 2012; 67: 311-318. [
DOI:10.1111/j.1600-0897.2012.01116.x]
23. Wang S, Zhu C, Zhang R, Liu L, Wu J. Association of interleukin 27 expression and p28 gene polymorphism with chronic hepatitis B virus infection. J Toxicol Environ Health Sci 2009; 1: 28-33.
24. Santos AS, Melo ME, Crisóstomo LG, Fukui RT, Matioli SR, Silva ME. Lack of association between IL27 gene variants and type 1 diabetes susceptibility. Cytokine 2013; 61: 349-352. [
DOI:10.1016/j.cyto.2012.12.003]
25. Huang N, Liu L, Wang XZ, Liu D, Yin SY, Yang XD. Association of interleukin (IL)-12 and IL-27 gene polymorphisms with chronic obstructive pulmonary disease in a Chinese population. DNA Cell Biol 2008; 27: 527-531. 26. Zhao H, Zhang Y, Xue F, Xu J, Fang Z. Interleukin-27 rs153109 polymorphism and the risk for immune thrombocytopenia. Autoimmunity 2013; 46: 509-512.
26. Zhao H, Zhang Y, Xue F, Xu J, Fang Z. Interleukin-27 rs153109 polymorphism and the risk for immune thrombocytopenia. Autoimmunity 2013; 46: 509-512. [
DOI:10.3109/08916934.2013.822072]